Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report-Reference-Cited by-同舟云学术

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report

Published:2019-04-10 Issue:5 Volume:10 Page:1285-1288
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Naito Tomoyuki¹^ORCID,Umemura Shigeki¹,Nakamura Hiroshi²,Zenke Yoshitaka¹,Udagawa Hibiki¹,Kirita Keisuke¹,Matsumoto Shingo¹,Yoh Kiyotaka¹,Niho Seiji¹,Motoi Noriko³,Aokage Keijyu⁴,Tsuboi Masahiro⁴,Ishii Genichiro²,Goto Koichi¹

Affiliation:

1. Department of Thoracic OncologyNational Cancer Center Hospital East Kashiwa Japan

2. Division of PathologyNational Cancer Center Hospital East Kashiwa Japan

3. Department of Pathology and Clinical LaboratoriesNational Cancer Center Hospital Tokyo Japan

4. Division of Thoracic SurgeryNational Cancer Center Hospital East Kashiwa Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13070

Reference19 articles.

1. SWI/SNF nucleosome remodellers and cancer

2. Loss of the SWI:SNF ATPase subunits BRM and BRG1 drives lung cancer development;Marquez‐Vilendrer SB;Oncoscience,2016

3. SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimens

4. BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization

5. SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First description of a primary SMARCA4-deficient carcinoma of the salivary glands;Human Pathology Reports;2024-11

2. Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy;Molecular Therapy;2024-08

3. SMARCA4-deficient non-small cell lung cancer: a case description and literature analysis;Quantitative Imaging in Medicine and Surgery;2024-06

4. Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods;Lung Cancer;2024-06

5. Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report;Frontiers in Immunology;2024-05-31